Rajnikant Patel: Bridging Ayurvedic Concepts and Modern Toxin-Mediated Disease
Rajnikant Patel, Senior Ayurvedic Consultant at Jiva Ayurveda, shared a post on LinkedIn:
”What if one of Ayurveda’s oldest clinical disciplines—Visha Chikitsa—has a much more contemporary relevance than we usually recognize?
A 29-year-old woman presented with a severe Hemolytic Uremic Syndrome (HUS).
Her initial condition was critical:
- Hemoglobin: 3 g/dL
- Platelets: 25,000/µL
- Serum creatinine: 3.5 mg/dL
- High-grade fever with rigors
- Orange-colored urine
- 8 sessions of dialysis plus 6 plasma therapies
Despite initial management, her hemoglobin again dropped, thrombocytopenia recurred, and the urine again became orange-colored.
She was subsequently referred for Ayurvedic management.
What happened next?
Ayurvedic treatment was initiated based on the clinical understanding of the condition through the lens of Visha Chikitsa.
Treatment:
- Shirish Tvak choorna
- Vilwadi gulika
- Vastiamyantik ghrita
- Nagarjunabhra rasa
- Over approximately 2 months:
Hemoglobin increased from approximately 7.0–8.0 g/dL to 12.3–12.7 g/dL.
Platelets increased from approximately 61,000–97,000/µL to 201,000–211,000/µL.
Serum creatinine, previously around 3.5 mg/dL, subsequently remained in the range of 1.3–2.6 mg/dL.
Clinically, the patient recovered sufficiently to resume her routine day-to-day activities without significant disturbance.
But here is the part that interests me most…
Modern medicine describes an important form of HUS as a toxin-mediated disease.
In Shiga-toxin–associated HUS, bacterial toxins can injure vascular endothelium. The toxin interacts with Gb3 receptors, which are highly expressed in renal microvascular tissue, contributing to endothelial injury, platelet activation and microvascular thrombosis—ultimately producing the characteristic triad of:
Hemolytic anemia plus thrombocytopenia plus acute kidney injury.
And Ayurveda has an entire clinical discipline devoted to understanding the effects of Visha — toxic substances and their systemic consequences.
This raises a fascinating question:
Can classical Ayurvedic concepts such as Visha Chikitsa provide useful conceptual frameworks for understanding modern toxin-mediated and infection-associated diseases?
- Bacterial toxins.
- Fungal toxins and virulence factors.
- Viral-mediated tissue injury.
- Environmental toxic exposures.
Perhaps the most productive approach is not to ask:
‘Ancient vs Modern?’
But rather:
‘What happens when classical Ayurvedic pathophysiology is studied alongside modern molecular pathogenesis?’ ”

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines